Ace Therapeutics excels in preclinical research for ocular therapies, offering preclinical studies to evaluate drug action, safety, and pharmacokinetics in the eye. We focus on optimizing early-stage development through pilot studies and proof-of-concept experiments to refine formulations for targeted ocular delivery.
